Premium Industrial News

Novartis To Make Pfizer/BioNTech COVID-19 Vaccine in Slovenia

Novartis To Make Pfizer/BioNTech COVID-19 Vaccine in Slovenia

Novartis To Make Pfizer/BioNTech COVID-19 Vaccine in Slovenia

Author: Martin Lynch | Published: October 29, 2021
Industry Segment: Pharmaceutical & Biotech  |  Word Count: 683 Words

GALWAY, IRELAND--November 2, 2021--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Novartis International AG (NYSE:NVS) (Basel, Switzerland) has inked a new deal to boost the manufacturing capacity of the Pfizer-BioNTech COVID-19 vaccine, COMINARTY, at its sterile fill-finish plant in Ljubljana, Slovenia.

Within this article: Details new manufacturing deal, new location, estimated capacity, related CureVac COVID-19 vaccine news

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?